{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": 9,
   "id": "839aeef7-8e83-486f-baf6-c47253742a75",
   "metadata": {},
   "outputs": [],
   "source": [
    "import pandas as pd\n",
    "import numpy as np\n",
    "import matplotlib.pyplot as plt\n",
    "import seaborn as sns\n",
    "import math\n",
    "import random"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 10,
   "id": "314ea898-cc4d-42af-80a4-d746fda12983",
   "metadata": {},
   "outputs": [],
   "source": [
    "df_imm = pd.read_excel(\"imm_pst_2021_2029.xlsx\", skiprows=2)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 11,
   "id": "57836c9d-56a0-4035-a690-ea828d60642e",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>INV Owner</th>\n",
       "      <th>Grantee/Vendor</th>\n",
       "      <th>INV Name</th>\n",
       "      <th>INV Total Amount</th>\n",
       "      <th>Workflow Step</th>\n",
       "      <th>AMD Type</th>\n",
       "      <th>INV Type</th>\n",
       "      <th>PMT Sequence</th>\n",
       "      <th>Payout Status</th>\n",
       "      <th>PMT Status</th>\n",
       "      <th>...</th>\n",
       "      <th>BoW Managing Sub-group</th>\n",
       "      <th>INV Managing Team</th>\n",
       "      <th>INV Coordinator</th>\n",
       "      <th>INV Start Date</th>\n",
       "      <th>INV End Date</th>\n",
       "      <th>INV ID</th>\n",
       "      <th>PMT ID</th>\n",
       "      <th>Business PMT ID</th>\n",
       "      <th>BoW ID</th>\n",
       "      <th>INV/AMD Show in Reporting</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>Amine El Mourid</td>\n",
       "      <td>NaN</td>\n",
       "      <td>MLE: Supplement to DRC 2025 survey</td>\n",
       "      <td>150000.0</td>\n",
       "      <td>Start Concept</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Grant</td>\n",
       "      <td>Initial</td>\n",
       "      <td>Potential</td>\n",
       "      <td>In Process</td>\n",
       "      <td>...</td>\n",
       "      <td>RISP &amp; RI Learning</td>\n",
       "      <td>Global Development\\Immunization</td>\n",
       "      <td>MJ Santiago</td>\n",
       "      <td>2025-05-01</td>\n",
       "      <td>2026-05-01</td>\n",
       "      <td>INV-085725</td>\n",
       "      <td>PYMT-291626</td>\n",
       "      <td>PYMT-291626</td>\n",
       "      <td>B01772</td>\n",
       "      <td>Yes</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>Amy Whalley</td>\n",
       "      <td>NaN</td>\n",
       "      <td>PLACEHOLDER - GR Japan</td>\n",
       "      <td>75001.0</td>\n",
       "      <td>Start Concept</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Grant</td>\n",
       "      <td>Initial</td>\n",
       "      <td>Potential</td>\n",
       "      <td>In Process</td>\n",
       "      <td>...</td>\n",
       "      <td>Immunization</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Matthew Kennelly</td>\n",
       "      <td>2025-06-01</td>\n",
       "      <td>2026-11-01</td>\n",
       "      <td>INV-070471</td>\n",
       "      <td>PYMT-230561</td>\n",
       "      <td>PYMT-230561</td>\n",
       "      <td>B03689</td>\n",
       "      <td>Yes</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>Amy Whalley</td>\n",
       "      <td>NaN</td>\n",
       "      <td>PLACEHOLDER - GR Japan</td>\n",
       "      <td>75001.0</td>\n",
       "      <td>Start Concept</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Grant</td>\n",
       "      <td>Subsequent</td>\n",
       "      <td>Potential</td>\n",
       "      <td>In Process</td>\n",
       "      <td>...</td>\n",
       "      <td>Immunization</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Matthew Kennelly</td>\n",
       "      <td>2025-06-01</td>\n",
       "      <td>2026-11-01</td>\n",
       "      <td>INV-070471</td>\n",
       "      <td>PYMT-230560</td>\n",
       "      <td>PYMT-230560</td>\n",
       "      <td>B03689</td>\n",
       "      <td>Yes</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>Chris Wolff</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NHSP funding Placeholder (for pipeline)</td>\n",
       "      <td>9750000.0</td>\n",
       "      <td>Start Concept</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Grant</td>\n",
       "      <td>Initial</td>\n",
       "      <td>Potential</td>\n",
       "      <td>In Process</td>\n",
       "      <td>...</td>\n",
       "      <td>Immunization Platforms</td>\n",
       "      <td>Global Development\\Immunization</td>\n",
       "      <td>Kelsey Vanhee</td>\n",
       "      <td>2025-05-01</td>\n",
       "      <td>2027-11-30</td>\n",
       "      <td>INV-088513</td>\n",
       "      <td>PYMT-300687</td>\n",
       "      <td>PYMT-300687</td>\n",
       "      <td>B05398</td>\n",
       "      <td>Yes</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>Chris Wolff</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NHSP funding Placeholder (for pipeline)</td>\n",
       "      <td>9750000.0</td>\n",
       "      <td>Start Concept</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Grant</td>\n",
       "      <td>Subsequent</td>\n",
       "      <td>Potential</td>\n",
       "      <td>In Process</td>\n",
       "      <td>...</td>\n",
       "      <td>Immunization Platforms</td>\n",
       "      <td>Global Development\\Immunization</td>\n",
       "      <td>Kelsey Vanhee</td>\n",
       "      <td>2025-05-01</td>\n",
       "      <td>2027-11-30</td>\n",
       "      <td>INV-088513</td>\n",
       "      <td>PYMT-300688</td>\n",
       "      <td>PYMT-300688</td>\n",
       "      <td>B05398</td>\n",
       "      <td>Yes</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>5 rows Ã— 34 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "         INV Owner Grantee/Vendor                                 INV Name  \\\n",
       "0  Amine El Mourid            NaN       MLE: Supplement to DRC 2025 survey   \n",
       "1      Amy Whalley            NaN                   PLACEHOLDER - GR Japan   \n",
       "2      Amy Whalley            NaN                   PLACEHOLDER - GR Japan   \n",
       "3      Chris Wolff            NaN  NHSP funding Placeholder (for pipeline)   \n",
       "4      Chris Wolff            NaN  NHSP funding Placeholder (for pipeline)   \n",
       "\n",
       "   INV Total Amount  Workflow Step AMD Type INV Type PMT Sequence  \\\n",
       "0          150000.0  Start Concept      NaN    Grant      Initial   \n",
       "1           75001.0  Start Concept      NaN    Grant      Initial   \n",
       "2           75001.0  Start Concept      NaN    Grant   Subsequent   \n",
       "3         9750000.0  Start Concept      NaN    Grant      Initial   \n",
       "4         9750000.0  Start Concept      NaN    Grant   Subsequent   \n",
       "\n",
       "  Payout Status  PMT Status  ...  BoW Managing Sub-group  \\\n",
       "0     Potential  In Process  ...      RISP & RI Learning   \n",
       "1     Potential  In Process  ...            Immunization   \n",
       "2     Potential  In Process  ...            Immunization   \n",
       "3     Potential  In Process  ...  Immunization Platforms   \n",
       "4     Potential  In Process  ...  Immunization Platforms   \n",
       "\n",
       "                 INV Managing Team   INV Coordinator  INV Start Date  \\\n",
       "0  Global Development\\Immunization       MJ Santiago      2025-05-01   \n",
       "1                              NaN  Matthew Kennelly      2025-06-01   \n",
       "2                              NaN  Matthew Kennelly      2025-06-01   \n",
       "3  Global Development\\Immunization     Kelsey Vanhee      2025-05-01   \n",
       "4  Global Development\\Immunization     Kelsey Vanhee      2025-05-01   \n",
       "\n",
       "   INV End Date      INV ID       PMT ID Business PMT ID  BoW ID  \\\n",
       "0    2026-05-01  INV-085725  PYMT-291626     PYMT-291626  B01772   \n",
       "1    2026-11-01  INV-070471  PYMT-230561     PYMT-230561  B03689   \n",
       "2    2026-11-01  INV-070471  PYMT-230560     PYMT-230560  B03689   \n",
       "3    2027-11-30  INV-088513  PYMT-300687     PYMT-300687  B05398   \n",
       "4    2027-11-30  INV-088513  PYMT-300688     PYMT-300688  B05398   \n",
       "\n",
       "  INV/AMD Show in Reporting  \n",
       "0                       Yes  \n",
       "1                       Yes  \n",
       "2                       Yes  \n",
       "3                       Yes  \n",
       "4                       Yes  \n",
       "\n",
       "[5 rows x 34 columns]"
      ]
     },
     "execution_count": 11,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df_imm.head()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 12,
   "id": "d14ad601-7392-4d04-adc5-137bad006207",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "(2682, 34)"
      ]
     },
     "execution_count": 12,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df_imm.shape"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 13,
   "id": "e6302e6d-63a3-4d6b-adf3-c2bec9731ac1",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "INV Owner                            object\n",
       "Grantee/Vendor                       object\n",
       "INV Name                             object\n",
       "INV Total Amount                    float64\n",
       "Workflow Step                        object\n",
       "AMD Type                             object\n",
       "INV Type                             object\n",
       "PMT Sequence                         object\n",
       "Payout Status                        object\n",
       "PMT Status                           object\n",
       "PMT Date                     datetime64[ns]\n",
       "PMT Total Amount                    float64\n",
       "PMT BoW Amount                      float64\n",
       "Low Forecast                        float64\n",
       "Expected Forecast                   float64\n",
       "High Forecast                       float64\n",
       "Forecast Comment                     object\n",
       "Forecast Type                        object\n",
       "Body of Work                         object\n",
       "BoW Funding Strategy                 object\n",
       "BoW Funding Group                    object\n",
       "BoW Funding Sub-group                object\n",
       "BoW Managing Strategy                object\n",
       "BoW Managing Group                   object\n",
       "BoW Managing Sub-group               object\n",
       "INV Managing Team                    object\n",
       "INV Coordinator                      object\n",
       "INV Start Date               datetime64[ns]\n",
       "INV End Date                 datetime64[ns]\n",
       "INV ID                               object\n",
       "PMT ID                               object\n",
       "Business PMT ID                      object\n",
       "BoW ID                               object\n",
       "INV/AMD Show in Reporting            object\n",
       "dtype: object"
      ]
     },
     "execution_count": 13,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df_imm.dtypes"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 14,
   "id": "d21bb983-9790-4fdb-b21a-b3526f3cd308",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "    PMT Date  Year\n",
      "0 2025-05-01  2025\n",
      "1 2025-01-05  2025\n",
      "2 2025-01-06  2025\n",
      "3 2025-09-04  2025\n",
      "4 2026-09-03  2026\n"
     ]
    }
   ],
   "source": [
    "# Convert PMT Date to datetime format\n",
    "df_imm[\"PMT Date\"] = pd.to_datetime(df_imm[\"PMT Date\"], errors=\"coerce\")\n",
    "\n",
    "#Extract the year\n",
    "df_imm[\"Year\"] = df_imm[\"PMT Date\"].dt.year\n",
    "\n",
    "# Inspect the results\n",
    "print(df_imm[[\"PMT Date\", \"Year\"]].head())"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 15,
   "id": "bbc1fa0c-70ec-43c0-8baf-fcc5651ced80",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "Index(['INV Owner', 'Grantee/Vendor', 'INV Name', 'INV Total Amount',\n",
       "       'Workflow Step', 'AMD Type', 'INV Type', 'PMT Sequence',\n",
       "       'Payout Status', 'PMT Status', 'PMT Date', 'PMT Total Amount',\n",
       "       'PMT BoW Amount', 'Low Forecast', 'Expected Forecast', 'High Forecast',\n",
       "       'Forecast Comment', 'Forecast Type', 'Body of Work',\n",
       "       'BoW Funding Strategy', 'BoW Funding Group', 'BoW Funding Sub-group',\n",
       "       'BoW Managing Strategy', 'BoW Managing Group', 'BoW Managing Sub-group',\n",
       "       'INV Managing Team', 'INV Coordinator', 'INV Start Date',\n",
       "       'INV End Date', 'INV ID', 'PMT ID', 'Business PMT ID', 'BoW ID',\n",
       "       'INV/AMD Show in Reporting', 'Year'],\n",
       "      dtype='object')"
      ]
     },
     "execution_count": 15,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df_imm.columns"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 16,
   "id": "76fe82c3-5aa0-4c2b-b98e-291de4e656f7",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Year                                                        2022  \\\n",
      "Body of Work                                                       \n",
      "Accelerate Measles coverage in Ethiopia                      NaN   \n",
      "Accelerate Measles coverage in Nigeria                       NaN   \n",
      "Accelerate Zero-dose learning                       1.100034e+07   \n",
      "Accelerate equitable HPV vx intros in Nigeria                NaN   \n",
      "Accelerate zero-dose learning in Ethiopia                    NaN   \n",
      "Accelerate zero-dose learning in Nigeria                     NaN   \n",
      "Build country-level political will for HPV immun.            NaN   \n",
      "COVID-19 Vaccine Programs and Delivery              3.527898e+06   \n",
      "Campaign Effectiveness                              4.803685e+06   \n",
      "Catalytic support to Gavi strategic priorities      6.235156e+05   \n",
      "Director's Reserve                                           NaN   \n",
      "Drive Vx Program Optimization & Prioritization               NaN   \n",
      "Eliminate & control vaccine preventable diseases    1.000000e+06   \n",
      "Ensure Future Vaccine Access                        4.832970e+05   \n",
      "Expand China National Immunization Program (NIP)    1.998645e+06   \n",
      "Foster Healthy Vaccine Markets and Ecosystem        4.751398e+06   \n",
      "Foster country policy and funding in Africa         2.733875e+06   \n",
      "Foster country policy and funding in South Asia     4.456864e+05   \n",
      "GDP Legacy                                          2.103695e+07   \n",
      "Gavi core contribution                              3.400000e+08   \n",
      "Global Vaccines Program Delivery                    8.771126e+06   \n",
      "HPV Vaccine Program Delivery                        3.519663e+06   \n",
      "Immunization Impact and Systems Modeling            4.291277e+06   \n",
      "Immunization Strategy & Business Support            4.930504e+06   \n",
      "Improve Deployment of Related Vaccine Products      2.939991e+06   \n",
      "Improve Supply Chain Visibility & Performance Mgmt  7.326928e+06   \n",
      "Influence and advance immunization agenda           3.360662e+06   \n",
      "Influence/advance global HPV immunization agendas            NaN   \n",
      "Measles Vaccine Program Delivery                    3.634832e+06   \n",
      "PAC RISP                                                     NaN   \n",
      "Priority Country RI support                         6.486567e+06   \n",
      "Secure sufficient funding for Gavi                  2.753201e+06   \n",
      "Strengthen Procurement Systems                               NaN   \n",
      "Strengthen RI in polio high risk geographies        9.644177e+06   \n",
      "Strengthen equitable access to HPV vx in Ethiopia            NaN   \n",
      "Strengthen global and regional partner ecosystem    2.081758e+06   \n",
      "Support the ecosystem to understand vaccine demand  6.981554e+06   \n",
      "Targeted Vaccines Program Delivery                  1.471726e+06   \n",
      "\n",
      "Year                                                        2023  \\\n",
      "Body of Work                                                       \n",
      "Accelerate Measles coverage in Ethiopia             1.250000e+05   \n",
      "Accelerate Measles coverage in Nigeria              2.761238e+06   \n",
      "Accelerate Zero-dose learning                       8.429882e+06   \n",
      "Accelerate equitable HPV vx intros in Nigeria       1.910928e+06   \n",
      "Accelerate zero-dose learning in Ethiopia           7.435440e+05   \n",
      "Accelerate zero-dose learning in Nigeria            2.929776e+06   \n",
      "Build country-level political will for HPV immun.   3.095087e+05   \n",
      "COVID-19 Vaccine Programs and Delivery              4.129494e+04   \n",
      "Campaign Effectiveness                              4.963863e+06   \n",
      "Catalytic support to Gavi strategic priorities      1.569932e+06   \n",
      "Director's Reserve                                           NaN   \n",
      "Drive Vx Program Optimization & Prioritization      9.529554e+05   \n",
      "Eliminate & control vaccine preventable diseases    5.004440e+05   \n",
      "Ensure Future Vaccine Access                        1.248425e+06   \n",
      "Expand China National Immunization Program (NIP)    2.078493e+06   \n",
      "Foster Healthy Vaccine Markets and Ecosystem        2.976067e+06   \n",
      "Foster country policy and funding in Africa         1.803538e+06   \n",
      "Foster country policy and funding in South Asia     7.902142e+05   \n",
      "GDP Legacy                                          2.361680e+07   \n",
      "Gavi core contribution                              3.400000e+08   \n",
      "Global Vaccines Program Delivery                    4.163933e+06   \n",
      "HPV Vaccine Program Delivery                        2.013182e+07   \n",
      "Immunization Impact and Systems Modeling            3.968504e+06   \n",
      "Immunization Strategy & Business Support            1.515221e+06   \n",
      "Improve Deployment of Related Vaccine Products      1.263985e+06   \n",
      "Improve Supply Chain Visibility & Performance Mgmt  6.494438e+06   \n",
      "Influence and advance immunization agenda           3.756174e+06   \n",
      "Influence/advance global HPV immunization agendas   9.385462e+05   \n",
      "Measles Vaccine Program Delivery                    7.860038e+06   \n",
      "PAC RISP                                            9.265063e+05   \n",
      "Priority Country RI support                         1.136838e+06   \n",
      "Secure sufficient funding for Gavi                  3.181062e+06   \n",
      "Strengthen Procurement Systems                      1.132428e+06   \n",
      "Strengthen RI in polio high risk geographies        1.676174e+07   \n",
      "Strengthen equitable access to HPV vx in Ethiopia   6.000000e+05   \n",
      "Strengthen global and regional partner ecosystem    1.692537e+07   \n",
      "Support the ecosystem to understand vaccine demand  5.686874e+06   \n",
      "Targeted Vaccines Program Delivery                  1.969247e+06   \n",
      "\n",
      "Year                                                        2024  \\\n",
      "Body of Work                                                       \n",
      "Accelerate Measles coverage in Ethiopia             3.226125e+06   \n",
      "Accelerate Measles coverage in Nigeria              1.249252e+06   \n",
      "Accelerate Zero-dose learning                       9.694240e+06   \n",
      "Accelerate equitable HPV vx intros in Nigeria       1.864925e+06   \n",
      "Accelerate zero-dose learning in Ethiopia           4.125000e+05   \n",
      "Accelerate zero-dose learning in Nigeria            2.310269e+06   \n",
      "Build country-level political will for HPV immun.   2.261999e+06   \n",
      "COVID-19 Vaccine Programs and Delivery                       NaN   \n",
      "Campaign Effectiveness                              1.617546e+06   \n",
      "Catalytic support to Gavi strategic priorities      3.151044e+06   \n",
      "Director's Reserve                                  2.740979e+06   \n",
      "Drive Vx Program Optimization & Prioritization      2.000316e+06   \n",
      "Eliminate & control vaccine preventable diseases    4.000000e+05   \n",
      "Ensure Future Vaccine Access                        1.402782e+06   \n",
      "Expand China National Immunization Program (NIP)    1.232019e+06   \n",
      "Foster Healthy Vaccine Markets and Ecosystem        4.868270e+06   \n",
      "Foster country policy and funding in Africa         1.198229e+06   \n",
      "Foster country policy and funding in South Asia     6.072833e+05   \n",
      "GDP Legacy                                          7.420846e+06   \n",
      "Gavi core contribution                              3.505000e+08   \n",
      "Global Vaccines Program Delivery                    1.059073e+06   \n",
      "HPV Vaccine Program Delivery                        8.748948e+06   \n",
      "Immunization Impact and Systems Modeling            4.820571e+06   \n",
      "Immunization Strategy & Business Support            8.811336e+05   \n",
      "Improve Deployment of Related Vaccine Products      2.442047e+06   \n",
      "Improve Supply Chain Visibility & Performance Mgmt  7.143923e+06   \n",
      "Influence and advance immunization agenda           3.839728e+06   \n",
      "Influence/advance global HPV immunization agendas   6.364942e+05   \n",
      "Measles Vaccine Program Delivery                    1.397293e+07   \n",
      "PAC RISP                                            1.202441e+06   \n",
      "Priority Country RI support                         1.771756e+06   \n",
      "Secure sufficient funding for Gavi                  4.163521e+06   \n",
      "Strengthen Procurement Systems                      4.472448e+06   \n",
      "Strengthen RI in polio high risk geographies        1.662090e+07   \n",
      "Strengthen equitable access to HPV vx in Ethiopia   2.626975e+06   \n",
      "Strengthen global and regional partner ecosystem    6.085084e+06   \n",
      "Support the ecosystem to understand vaccine demand  4.619856e+06   \n",
      "Targeted Vaccines Program Delivery                  4.133896e+05   \n",
      "\n",
      "Year                                                        2025  \\\n",
      "Body of Work                                                       \n",
      "Accelerate Measles coverage in Ethiopia             1.790769e+06   \n",
      "Accelerate Measles coverage in Nigeria              1.728831e+06   \n",
      "Accelerate Zero-dose learning                       9.711678e+06   \n",
      "Accelerate equitable HPV vx intros in Nigeria       1.270820e+05   \n",
      "Accelerate zero-dose learning in Ethiopia           1.095834e+06   \n",
      "Accelerate zero-dose learning in Nigeria            1.471282e+06   \n",
      "Build country-level political will for HPV immun.   5.703941e+05   \n",
      "COVID-19 Vaccine Programs and Delivery             -3.052290e+05   \n",
      "Campaign Effectiveness                              1.705333e+06   \n",
      "Catalytic support to Gavi strategic priorities      2.586925e+06   \n",
      "Director's Reserve                                  1.023130e+06   \n",
      "Drive Vx Program Optimization & Prioritization      1.040396e+06   \n",
      "Eliminate & control vaccine preventable diseases    3.272855e+06   \n",
      "Ensure Future Vaccine Access                        7.097000e+05   \n",
      "Expand China National Immunization Program (NIP)    1.950000e+06   \n",
      "Foster Healthy Vaccine Markets and Ecosystem        5.359509e+06   \n",
      "Foster country policy and funding in Africa                  NaN   \n",
      "Foster country policy and funding in South Asia              NaN   \n",
      "GDP Legacy                                          7.213404e+06   \n",
      "Gavi core contribution                              3.295000e+08   \n",
      "Global Vaccines Program Delivery                    4.286951e+05   \n",
      "HPV Vaccine Program Delivery                        1.804586e+07   \n",
      "Immunization Impact and Systems Modeling            3.602644e+06   \n",
      "Immunization Strategy & Business Support            1.098884e+06   \n",
      "Improve Deployment of Related Vaccine Products      1.125000e+06   \n",
      "Improve Supply Chain Visibility & Performance Mgmt  4.814304e+06   \n",
      "Influence and advance immunization agenda           6.763892e+05   \n",
      "Influence/advance global HPV immunization agendas   1.182864e+06   \n",
      "Measles Vaccine Program Delivery                    1.194290e+07   \n",
      "PAC RISP                                            1.099000e+06   \n",
      "Priority Country RI support                         3.782300e+06   \n",
      "Secure sufficient funding for Gavi                  4.753094e+06   \n",
      "Strengthen Procurement Systems                      2.410345e+06   \n",
      "Strengthen RI in polio high risk geographies        1.319149e+07   \n",
      "Strengthen equitable access to HPV vx in Ethiopia   1.247776e+06   \n",
      "Strengthen global and regional partner ecosystem    7.977706e+06   \n",
      "Support the ecosystem to understand vaccine demand  2.080119e+06   \n",
      "Targeted Vaccines Program Delivery                  9.756620e+05   \n",
      "\n",
      "Year                                                        2026  \\\n",
      "Body of Work                                                       \n",
      "Accelerate Measles coverage in Ethiopia             7.662930e+05   \n",
      "Accelerate Measles coverage in Nigeria              1.831998e+06   \n",
      "Accelerate Zero-dose learning                       3.616340e+06   \n",
      "Accelerate equitable HPV vx intros in Nigeria       1.265810e+05   \n",
      "Accelerate zero-dose learning in Ethiopia           4.022890e+05   \n",
      "Accelerate zero-dose learning in Nigeria            1.098639e+06   \n",
      "Build country-level political will for HPV immun.   7.880300e+04   \n",
      "COVID-19 Vaccine Programs and Delivery                       NaN   \n",
      "Campaign Effectiveness                                       NaN   \n",
      "Catalytic support to Gavi strategic priorities      2.071640e+06   \n",
      "Director's Reserve                                  7.960000e+05   \n",
      "Drive Vx Program Optimization & Prioritization               NaN   \n",
      "Eliminate & control vaccine preventable diseases    4.528195e+06   \n",
      "Ensure Future Vaccine Access                                 NaN   \n",
      "Expand China National Immunization Program (NIP)    1.550000e+06   \n",
      "Foster Healthy Vaccine Markets and Ecosystem        1.753741e+06   \n",
      "Foster country policy and funding in Africa         1.250000e+05   \n",
      "Foster country policy and funding in South Asia              NaN   \n",
      "GDP Legacy                                          7.895616e+06   \n",
      "Gavi core contribution                              3.400000e+08   \n",
      "Global Vaccines Program Delivery                    2.000000e+04   \n",
      "HPV Vaccine Program Delivery                        8.196006e+06   \n",
      "Immunization Impact and Systems Modeling            1.471484e+06   \n",
      "Immunization Strategy & Business Support            4.920000e+04   \n",
      "Improve Deployment of Related Vaccine Products      1.153494e+06   \n",
      "Improve Supply Chain Visibility & Performance Mgmt  9.750413e+05   \n",
      "Influence and advance immunization agenda           1.511770e+05   \n",
      "Influence/advance global HPV immunization agendas   4.468956e+05   \n",
      "Measles Vaccine Program Delivery                    3.988393e+06   \n",
      "PAC RISP                                            4.259980e+05   \n",
      "Priority Country RI support                         8.841820e+05   \n",
      "Secure sufficient funding for Gavi                  2.552663e+06   \n",
      "Strengthen Procurement Systems                               NaN   \n",
      "Strengthen RI in polio high risk geographies        8.218258e+06   \n",
      "Strengthen equitable access to HPV vx in Ethiopia            NaN   \n",
      "Strengthen global and regional partner ecosystem    3.071758e+06   \n",
      "Support the ecosystem to understand vaccine demand  1.105498e+06   \n",
      "Targeted Vaccines Program Delivery                  4.114380e+05   \n",
      "\n",
      "Year                                                        2027         2028  \\\n",
      "Body of Work                                                                    \n",
      "Accelerate Measles coverage in Ethiopia                      NaN          NaN   \n",
      "Accelerate Measles coverage in Nigeria                       NaN          NaN   \n",
      "Accelerate Zero-dose learning                       2.750000e+06          NaN   \n",
      "Accelerate equitable HPV vx intros in Nigeria                NaN          NaN   \n",
      "Accelerate zero-dose learning in Ethiopia           3.333333e+05     250000.0   \n",
      "Accelerate zero-dose learning in Nigeria            2.651900e+04          NaN   \n",
      "Build country-level political will for HPV immun.            NaN          NaN   \n",
      "COVID-19 Vaccine Programs and Delivery                       NaN          NaN   \n",
      "Campaign Effectiveness                                       NaN          NaN   \n",
      "Catalytic support to Gavi strategic priorities               NaN          NaN   \n",
      "Director's Reserve                                  7.680000e+05     451000.0   \n",
      "Drive Vx Program Optimization & Prioritization               NaN          NaN   \n",
      "Eliminate & control vaccine preventable diseases    5.900000e+06          NaN   \n",
      "Ensure Future Vaccine Access                                 NaN          NaN   \n",
      "Expand China National Immunization Program (NIP)             NaN          NaN   \n",
      "Foster Healthy Vaccine Markets and Ecosystem                 NaN          NaN   \n",
      "Foster country policy and funding in Africa                  NaN          NaN   \n",
      "Foster country policy and funding in South Asia              NaN          NaN   \n",
      "GDP Legacy                                          9.970000e+04          NaN   \n",
      "Gavi core contribution                              3.400000e+08  340000000.0   \n",
      "Global Vaccines Program Delivery                             NaN          NaN   \n",
      "HPV Vaccine Program Delivery                        1.618859e+06     775000.0   \n",
      "Immunization Impact and Systems Modeling            4.778470e+05          NaN   \n",
      "Immunization Strategy & Business Support                     NaN          NaN   \n",
      "Improve Deployment of Related Vaccine Products      7.505790e+05          NaN   \n",
      "Improve Supply Chain Visibility & Performance Mgmt  5.134260e+05          NaN   \n",
      "Influence and advance immunization agenda           1.294154e+05          NaN   \n",
      "Influence/advance global HPV immunization agendas   1.943956e+05          NaN   \n",
      "Measles Vaccine Program Delivery                    2.784700e+04          NaN   \n",
      "PAC RISP                                                     NaN          NaN   \n",
      "Priority Country RI support                                  NaN          NaN   \n",
      "Secure sufficient funding for Gavi                  2.152928e+06     896062.5   \n",
      "Strengthen Procurement Systems                               NaN          NaN   \n",
      "Strengthen RI in polio high risk geographies        5.635865e+06          NaN   \n",
      "Strengthen equitable access to HPV vx in Ethiopia            NaN          NaN   \n",
      "Strengthen global and regional partner ecosystem             NaN          NaN   \n",
      "Support the ecosystem to understand vaccine demand  1.108850e+05          NaN   \n",
      "Targeted Vaccines Program Delivery                           NaN          NaN   \n",
      "\n",
      "Year                                                       2029  \n",
      "Body of Work                                                     \n",
      "Accelerate Measles coverage in Ethiopia                     NaN  \n",
      "Accelerate Measles coverage in Nigeria                      NaN  \n",
      "Accelerate Zero-dose learning                               NaN  \n",
      "Accelerate equitable HPV vx intros in Nigeria               NaN  \n",
      "Accelerate zero-dose learning in Ethiopia                   NaN  \n",
      "Accelerate zero-dose learning in Nigeria                    NaN  \n",
      "Build country-level political will for HPV immun.           NaN  \n",
      "COVID-19 Vaccine Programs and Delivery                      NaN  \n",
      "Campaign Effectiveness                                      NaN  \n",
      "Catalytic support to Gavi strategic priorities              NaN  \n",
      "Director's Reserve                                     328255.0  \n",
      "Drive Vx Program Optimization & Prioritization              NaN  \n",
      "Eliminate & control vaccine preventable diseases            NaN  \n",
      "Ensure Future Vaccine Access                                NaN  \n",
      "Expand China National Immunization Program (NIP)            NaN  \n",
      "Foster Healthy Vaccine Markets and Ecosystem                NaN  \n",
      "Foster country policy and funding in Africa                 NaN  \n",
      "Foster country policy and funding in South Asia             NaN  \n",
      "GDP Legacy                                                  NaN  \n",
      "Gavi core contribution                              340000000.0  \n",
      "Global Vaccines Program Delivery                            NaN  \n",
      "HPV Vaccine Program Delivery                                NaN  \n",
      "Immunization Impact and Systems Modeling                    NaN  \n",
      "Immunization Strategy & Business Support                    NaN  \n",
      "Improve Deployment of Related Vaccine Products              NaN  \n",
      "Improve Supply Chain Visibility & Performance Mgmt          NaN  \n",
      "Influence and advance immunization agenda                   NaN  \n",
      "Influence/advance global HPV immunization agendas           NaN  \n",
      "Measles Vaccine Program Delivery                            NaN  \n",
      "PAC RISP                                                    NaN  \n",
      "Priority Country RI support                                 NaN  \n",
      "Secure sufficient funding for Gavi                          NaN  \n",
      "Strengthen Procurement Systems                              NaN  \n",
      "Strengthen RI in polio high risk geographies                NaN  \n",
      "Strengthen equitable access to HPV vx in Ethiopia           NaN  \n",
      "Strengthen global and regional partner ecosystem            NaN  \n",
      "Support the ecosystem to understand vaccine demand          NaN  \n",
      "Targeted Vaccines Program Delivery                          NaN  \n"
     ]
    }
   ],
   "source": [
    "# create pivot table\n",
    "pivot_bow = df_imm.pivot_table(values=\"PMT BoW Amount\", index=\"Body of Work\", columns=\"Year\", aggfunc=\"sum\")\n",
    "print(pivot_bow)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "091b92d0-7674-429b-b5e8-0569ada46659",
   "metadata": {},
   "outputs": [],
   "source": []
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python 3 (ipykernel)",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.11.7"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 5
}
